Laval – In June 2022, the Government of Canada established a long-term agreement with Moderna for the domestic production of messenger RNA (mRNA) vaccines in Canada. The negotiations began in 2021, during the depths of the COVID-19 pandemic, as the country faced intense global competition to secure vaccines. This global supply chain vulnerability showcased the need to ensure domestic capacity …
Ottawa – In the 2023 federal budget, Liberals invested more than $200 billion over 10 years to support the Working Together to Improve Health Care for Canadians Plan. Through this plan, we will work collaboratively with provinces and territories on 4 shared health priorities: expanding access to family health services, including in rural and remote areas supporting health workers and …
Ottawa – In Canada, 2 new cases of measles and no new cases of rubella were reported in week 6, 2024. Currently, there are 4 active cases of measles and 1 active case of congenital rubella syndrome in Canada. 4 cases of measles and no cases of rubella have been reported in Canada in 2024. Canadians travelling outside of Canada are …
London – AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) who have received prior systemic therapy. The Prescription Drug User Fee Act date, the Food and Drug Administration (FDA) action date for its …
First EGFR inhibitor and targeted treatment to demonstrate progression-free survival benefit in Stage III setting London – Positive high-level results from the LAURA Phase III trial showed AstraZeneca’s Tagrisso (osimertinib) demonstrated a statistically significant and highly clinically meaningful improvement in progression-free survival (PFS) for patients with unresectable, Stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after chemoradiotherapy …
Laval business receives $200,000 in financial assistance from CED. Laval – Supporting growth through innovation contributes to economic development in Quebec’s regions. That is why Annie Koutrakis, Member of Parliament for Vimy and Parliamentary Secretary to the Minister of Tourism and Minister responsible for CED, today announced a repayable contribution of $200,000 for RNA Technologies & Therapeutics Inc. (RNA T&T). This CED support has enabled the business to acquire …
Ottawa – The Patented Medicine Prices Review Board (PMPRB) has published its What We Learned Report, which summarizes the feedback received in the Policy Roundtable meetings it hosted in December. The report, along with the written submissions received, will help inform the PMPRB’s next steps toward developing new Guidelines. The What We Learned Report is a summary of the opinions …
KIRKLAND – Pfizer Canada announced that Health Canada has granted a Notice of Compliance with conditions (NOC/c) to ELREXFIO (elranatamab solution for injection). ELREXFIO is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM) who have received at least three prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody, …
Ottawa – During Sexual Health Week, Chief Public Health Officer of Canada Theresa Tam took opportunity to bring attention to the serious health risk posed by syphilis in Canada and the importance of early testing to change the recent upward trajectory in new cases. She said: “Canada, like many countries, has experienced an alarming increase in syphilis cases. In 2022, there were …
Yellowknife – Canadians deserve a health care system that provides them with timely access to health services whenever and wherever they are needed, as well as the ability to age with dignity closer to home. Mark Holland, Canada’s Minister of Health, Ya’ara Saks, Canada’s Minister of Mental Health and Addictions and Associate Minister of Health, and Lesa Semmler, Minister of …
